NCT05927181

Brief Summary

The aim was to compare two protocols for immediate implants with fixed provisional restoration, no grafting (trimodal approach=TA) versus grafting both osseous gap and peri-implant mucosa (trimodal approach with modification of the osseous and mucosal compartments =TAOM) by measuring the soft tissue changes overtime. The periodontal phenotype was registered, to investigate a relationship between its thickness and the clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
3.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

May 19, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 3, 2023

Completed
Last Updated

July 3, 2023

Status Verified

May 1, 2023

Enrollment Period

6.9 years

First QC Date

May 19, 2023

Last Update Submit

June 21, 2023

Conditions

Keywords

Immediate Implantssoft tissue graftimmediate implant restoration

Outcome Measures

Primary Outcomes (1)

  • Distance from measuring points on the reference stent to gingival zenith of the implant restoration in tenths of a milimetre by means of a precision digital calliper.

    Vertical midfacial soft tissue change from baseline (before tooth extraction) to 12 months following implant placement.

    12 months

Secondary Outcomes (2)

  • Distance from measuring points on the reference stent to mesial and distal papillae of the implant restoration in tenths of a milimetres by means of a precision digital calliper.

    12 months

  • Periodontal thickness at 5mm apical to the gingival margin in tenths of a milimetre.

    Baseline

Study Arms (2)

Trimodal Approach with Osseous and Mucosal compartment modification: TAOM

EXPERIMENTAL

Flapless immediate implant placement and provisional restoration with alveolar filling and connective tissue graft.

Procedure: TAOM

Trimodal Approach: TA

ACTIVE COMPARATOR

Flapless immediate implant placement and provisional restoration.

Procedure: TAOM

Interventions

TAOMPROCEDURE

In the TAOM group, the gap between the implant and the facial bone wall was grafted with inorganic bovine bone (Geistlich Bio-Oss®; Geistlich Pharma AG, Wolhusen, Switzerland) and, in addition, a connective tissue graft (CTG) was placed submucosally on the labial bone plate by means of an envelope technique.

Also known as: Trimodal approach with osseous and mucosal interventions.
Trimodal Approach with Osseous and Mucosal compartment modification: TAOMTrimodal Approach: TA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Need for tooth extraction in the anterior maxilla (13-23) due to cavities, internal resorption, fractures, restorative problems, endodontic complications and prosthetic reasons.
  • The failing tooth has adjacent and opposing natural teeth
  • Adequate oral hygiene (Bleeding on probing \<20%; Plaque index \<20%);
  • Absence of active and uncontrolled periodontal disease
  • Sufficient mesial-distal and interocclusal space for implant placement and definitive restoration
  • Sufficient interocclusal space to design a non-occluding provisional restoration

You may not qualify if:

  • Systemic metabolic or osseous disease that could compromise peri-implant tissue healing.
  • Acute infection in the treatment area
  • Absence of one or both adjacent teeth
  • Non-integrity of the buccal bone wall (dehiscence or fenestration) observed during surgery, or when tooth extraction has altered the integrity of the osseous and gingival architecture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maria Del Rosario Rioboo Crespo

Madrid, 28003, Spain

Location

Study Officials

  • Gustavo G Cabello

    Private Practice, Málaga, Spain

    PRINCIPAL INVESTIGATOR
  • Javier J Fabrega

    Private Practice, Madrid, Spain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2023

First Posted

July 3, 2023

Study Start

April 1, 2009

Primary Completion

March 1, 2016

Study Completion

February 1, 2020

Last Updated

July 3, 2023

Record last verified: 2023-05

Locations